These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 696249)

  • 1. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
    Lähteenmäki P
    Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovulation inhibition with a combined oral contraceptive containing 20 micrograms ethinyl estradiol and 250 micrograms levonorgestrel. Serum levels of the active ingredients and FSH, LH, estradiol 17-beta and progesterone.
    Lunell NO; Carlström K; Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():17-21. PubMed ID: 294110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal content of plasma and endometrium of women taking oral contraceptives.
    Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V
    Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.
    Forleo R; Vegna G; Pala A
    Acta Eur Fertil; 1972 Jun; 3(2):159-76. PubMed ID: 4679575
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate postabortal contraception with a microdose combined preparation: suppression of pituitary and ovarian function and elimination of HCG.
    Lähteenmäki P; Luukkainen T
    Contraception; 1978 Feb; 17(2):169-81. PubMed ID: 630887
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate postabortal insertion of a levonorgestrel-releasing IUD.
    Heikkilä M; Lähteenmäki P; Luukkainen T
    Contraception; 1982 Sep; 26(3):245-59. PubMed ID: 6816506
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of different types of oral contraceptives upon ovarian function (author's transl)].
    Aktories K; Krög W; Dericks-Tan JS; Jürgensen O; Taubert HD
    Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):318-26. PubMed ID: 1269893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of low dose of oestrogen-progestagen combination upon FSH and LH (author's transl)].
    Mezzana F; Netter A; Levy C; Rozenbaum H
    Contracept Fertil Sex (Paris); 1975 Jan; 3(1):7-10. PubMed ID: 1164947
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiepileptic drugs and oral contraceptives. Preliminary note].
    Meduri M; Bramanti B; Di Perri R; Volpe A; Oliva A; Baviera G
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2462-7. PubMed ID: 756744
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function.
    Tsai CC; Yen SS
    J Clin Endocrinol Metab; 1971 Dec; 33(6):917-23. PubMed ID: 5135633
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of norgestrel administered intermittently on pituitary ovarian function.
    Craft I; Foss GL; Warren RJ; Fotherby K
    Contraception; 1975 Nov; 12(5):589-98. PubMed ID: 1192745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacology of hormonal contraceptives].
    Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
    Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary-ovarian activity when switching from various monophasic pills to a triphasic pill.
    Eyong E; Priddy AR; Killick SR; Elstein M
    Adv Contracept; 1989 Mar; 5(1):1-11. PubMed ID: 2528892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations with Ovidon.
    Farkas M; Falkay G; Szigethy A
    Ther Hung; 1977; 25(3):93-101. PubMed ID: 929481
    [No Abstract]   [Full Text] [Related]  

  • 17. Feedback control of pituitary gonadotropins.
    Odell WD; Swerdloff RS
    Adv Biosci; 1975; 15():141-62. PubMed ID: 51805
    [No Abstract]   [Full Text] [Related]  

  • 18. A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
    Xu Y; Gabriel K; Wang Y; Zhou Y; Eisele O; Vutikullird A; Mikol DD; Lee E
    CNS Drugs; 2019 May; 33(5):513-522. PubMed ID: 30963506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
    Farkas M
    Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ethinyl estradiol administration during the follicular phase of the menstrual cycle on LH, FSH, progesterone and estradiol levels in the subsequent luteal phase.
    Dhont M; Vandekerckhove D; Vermeulen A
    J Clin Endocrinol Metab; 1974 Sep; 39(3):465-70. PubMed ID: 4416191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.